{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://aminextx.com/#organization",
      "name": "Aminex – Empowering the Immune System Against Cancer",
      "url": "https://aminextx.com/",
      "description": "Aminex – Empowering the Immune System Against Cancer Aminex About Overview Management Board Science Polyamine Depletion Publications Clinical Trials News Contact Us Advancing a novel, metabolic-targeted therapy – AMXT 1501 – to treat adult and pediatric cancers Learn More Scroll Aminex Therapeutics, Inc. is a drug development company focused on advancing a novel immunotherapy for the treatment of cancer. The Science Polyamine Depletion Therapy Aminex Therapeutics’ immuno-oncology approach significantly reduces the uptake and production of polyamines – molecules found in high concentrations in cancer cells and the tumor microenvironment and linked to immune system suppression."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/aminex-and-8211-empowering-the-immune-system-against-cancer#asg",
      "name": "Aminex – Empowering the Immune System Against Cancer ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/aminex-and-8211-empowering-the-immune-system-against-cancer",
      "isPartOf": {
        "@id": "https://aminextx.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}